Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

OPERATING SEGMENTS

v3.25.1
OPERATING SEGMENTS
 12 Months Ended
Dec. 31, 2024
Disclosure of operating segments [abstract]  
OPERATING SEGMENTS [Text Block]
NOTE 23 -
OPERATING SEGMENTS
 
  A.
General information:
 
Since inception date, the operation of the Group has been conducted through one operating segment, (i.e., sales of medical cannabis products and other products) to customers through certain geographical areas (i.e. Israel and Germany).
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
Year ended December 31, 2024
                        
                         
Revenue
  
$
38,523
    
$
15,508
    
$
-
    
$
54,031
  
                                 
Segment loss
  
$
(9,314
)
  
$
942
    
$
-
    
$
(8,372
)
                                 
Unallocated corporate expenses
                  
$
(1,862
)
  
$
(1,862
)
                                 
Total operating loss
                          
$
(10,234
)
                                 
Depreciation and amortization
  
$
2,014
    
$
170
    
$
-
    
$
2,184
  
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
Year ended December 31, 2023
                        
                         
Revenue
  
$
43,316
    
$
5,488
    
$
-
    
$
48,804
  
                                 
Segment loss
  
$
(6,627
)
  
$
(1,615
)
  
$
-
    
$
(8,242
)
                                 
Unallocated corporate expenses
                  
$
(4,550
)
  
$
(4,550
)
                                 
Total operating loss
                          
$
(12,792
)
                                 
Depreciation and amortization
  
$
2,823
    
$
173
    
$
-
    
$
2,996
  
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
Year ended December 31, 2022
                        
                         
Revenue
  
$
50,500
    
$
3,835
    
$
-
    
$
54,335
  
                                 
Segment loss
  
$
(23,606
)
  
$
(3,225
)
  
$
-
    
$
(26,831
)
                                 
Unallocated corporate expenses
                  
$
(3,960
)
  
$
(3,960
)
                                 
Total operating loss
                          
$
(30,791
)
                                 
Depreciation and amortization
  
$
1,424
    
$
701
    
$
-
    
$
2,125
  
 
  B.
Major customers
 
During the year ended December 31, 2024, the Company had two customers which accounted for approximately 32% of the Group's total revenue. During the years ended December 31, 2023 and 2022, the Company had no customer that individually is exceeding 10% of the Group's total revenue.